Our clinical thalassemia program consists of a pediatric unit and an adult unit, with a seamless transition program connecting the two. Each unit has a dedicated physician, and the program is supported by a practitioner who bridges the two units. Transfusions are administered in state-of-the-art outpatient pediatric and adult infusion centers, supported by NewYork-Presbyterian/Weill Cornell Medicine blood bank and laboratory facilities.
Open Clinical Trials
We are committed to advancing thalassemia patient care and facilitating the development of novel treatments through research studies and clinical trials. The development of new strategies, including disease-modifying and curative therapies, form the basis of our progressive approach to thalassemia management for patients at Weill Cornell Medicine.